Stock upgrades: editas medicine shows rising relative strength


Play all audios:

Loading...

On Monday, Editas Medicine (EDIT) got an upgrade to its Relative Strength (RS) Rating, from 78 to 86. When you're researching the best stocks to buy and watch, be sure to pay attention


to relative price strength. IBD's proprietary rating measures price performance with a 1 (worst) to 99 (best) score. The score shows how a stock's price performance over…